Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunphenon EGCg in Early Alzheimer's Disease
NCT00951834Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2009
- Primary completion
- Feb 2015
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sunphenon EGCG in Alzheimer's disease (AD), sponsored by Charité – Universitätsmedizin Berlin. Started Oct 2009; status: completed.
02
Drugs
Sunphenon EGCG
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00951834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00951834.